Tag: Michael Kuss

Premier Voices #4: The Placebo Problem Part 2 With Michael Kuss

Measuring, interpreting, and mitigating placebo response is a persistent and growing challenge in analgesia clinical trials. In the conclusion of our Premier Voices podcast series on the placebo problem, Paul Mirek, Marketing Manager, and Michael Kuss, BS, Vice President, Analgesia Product Development, examine experimental trial designs, inclusion and exclusion criteria, and other approaches to managing the...

Pain Expert to Discuss Osteoarthritis Trials at APS 2018

DURHAM, N.C., MARCH 2, 2018 — You know that well-worn advice about picking investments: that past performance doesn’t guarantee future results. The same can be said of selecting clinical trial sites, as Premier Research’s top analgesia expert will explore at the American Pain Society’s 2018 Scientific Summit on March 6 in Anaheim. Michael Kuss, Vice...

April 12 Webinar Examines Preclinical Research in Acute Pain Studies

DURHAM, N.C., April 12, 2016 — Study of acute pain drugs can benefit greatly from preclinical research. Premier Research will explain why and how in a webinar on Tuesday, April 12. The hour-long event will begin at 11 a.m. EDT / 4 p.m. BST / 5 p.m. CEST. Evaluating a medication for acute pain typically starts...